Tvardi Therapeutics, Inc.(TVRD)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | Posner Christopher PRESIDENT AND CEO | Sale | -583 | -4.26%13,109 | $4.75 | $2,769 | View SEC filing | |
| 2025-03-04 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | -163 | -2.22%7,190 | $4.76 | $776 | View SEC filing | |
| 2025-02-06 | Posner Christopher PRESIDENT AND CEO | Sale | -372 | -2.65%13,692 | $4.72 | $1,756 | View SEC filing | |
| 2024-11-06 | Posner Christopher PRESIDENT AND CEO | Sale | -3,668 | -2.13%168,768 | $0.29 | $1,064 | View SEC filing | |
| 2024-08-02 | Posner Christopher PRESIDENT AND CEO | Sale | -4,149 | -2.35%172,436 | $0.35 | $1,452 | View SEC filing | |
| 2024-05-06 | Posner Christopher PRESIDENT AND CEO | Sale | -3,936 | -2.18%176,585 | $0.75 | $2,952 | View SEC filing | |
| 2024-04-09 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | -2,753 | -4.91%53,365 | $0.83 | $2,285 | View SEC filing | |
| 2024-04-09 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | -2,753 | -3.03%88,247 | $0.83 | $2,285 | View SEC filing | |
| 2024-03-04 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | -3,293 | -3.49%91,000 | $0.89 | $2,931 | View SEC filing | |
| 2024-03-04 | Posner Christopher PRESIDENT AND CEO | Sale | -5,834 | -3.13%180,521 | $0.89 | $5,192 | View SEC filing | |
| 2024-03-04 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | -3,293 | -5.54%56,118 | $0.89 | $2,931 | View SEC filing | |
| 2024-02-12 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | -7,770 | -7.61%94,293 | $0.53 | $4,118 | View SEC filing | |
| 2024-02-12 | Maynard Ryan D CHIEF FINANCIAL OFFICER | Sale | -5,488 | -40.65%8,012 | $0.53 | $2,909 | View SEC filing | |
| 2024-02-12 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | -7,770 | -11.57%59,411 | $0.53 | $4,118 | View SEC filing | |
| 2024-02-12 | Posner Christopher PRESIDENT AND CEO | Sale | -35,575 | -16.03%186,355 | $0.53 | $18,855 | View SEC filing | |
| 2024-02-05 | Posner Christopher PRESIDENT AND CEO | Sale | -4,981 | -2.20%221,930 | $0.55 | $2,740 | View SEC filing | |
| 2023-11-03 | Posner Christopher President and CEO | Sale | -3,796 | -2.26%164,411 | $1.22 | $4,631 | View SEC filing | |
| 2023-08-04 | Posner Christopher President and CEO | Sale | -4,307 | -2.50%168,207 | $3.07 | $13,222 | View SEC filing | |
| 2023-06-27 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | -2,483 | -2.73%88,563 | $3.51 | $8,715 | View SEC filing | |
| 2023-06-27 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | -2,993 | -1.91%153,747 | $3.51 | $10,505 | View SEC filing | |
| 2023-06-27 | Goncalves Joana Chief Medical Officer | Sale | -2,723 | -4.83%53,681 | $3.51 | $9,558 | View SEC filing | |
| 2023-05-09 | Posner Christopher President and CEO | Sale | -3,869 | -2.19%172,514 | $4.40 | $17,024 | View SEC filing | |
| 2023-04-06 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | -2,481 | -2.65%91,046 | $4.91 | $12,182 | View SEC filing | |
| 2023-04-06 | Goncalves Joana Chief Medical Officer | Sale | -2,481 | -4.21%56,404 | $4.91 | $12,182 | View SEC filing | |
| 2023-04-06 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | -2,733 | -1.71%156,740 | $4.91 | $13,419 | View SEC filing |
1-25 of 196